Edwards Larry Todd 4
4 · Arcutis Biotherapeutics, Inc. · Filed Oct 3, 2024
Insider Transaction Report
Form 4
Edwards Larry Todd
See Remarks
Transactions
- Sale
Common Stock
2024-10-02$10.01/sh−3,725$37,295→ 136,635 total
Footnotes (2)
- [F1]The sale was made pursuant to the Issuer's mandatory sell-to-cover requirements implemented to satisfy the tax withholding obligations associated with the vesting of the Reporting Person's Restricted Stock Units ("RSUs").
- [F2]The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $9.51 to $10.31, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.